Who
Jack H. Dean
Director
Company insider
Files Form 4 as: Director, Acurx Pharmaceuticals; Director, Dipexium Pharmaceuticals; Director, Research Pharmaceutical Services.
In numbers
- Trades disclosed
- 13
- Buys
- 3
- Sells
- 0
- Bought
- $62K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 Aug 2008
- Last trade
- 20 Apr 2026
- Last filed
- 22 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,150 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,150 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —9,852 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $10K9,852 at $1.02 | filing |
| 17 Jun 2024filed 18 Jun 2024 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 Jan 2017filed 20 Apr 2017 | Dipexium Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 19 Jan 2016filed 21 Jan 2016 | Dipexium Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | $183K18,000 at $10.16 | filing |
| 5 Jan 2015filed 2 Feb 2015 | Dipexium Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | $170K15,000 at $11.35 | filing |
| 21 May 2014filed 22 May 2014 | Dipexium Pharmaceuticals | SEC FORM 4 Bought | $27K3,000 at $9.00 | filing |
| 18 Mar 2014filed 20 Mar 2014 | Dipexium Pharmaceuticals | SEC FORM 4 Bought | $25K2,083 at $12.00 | filing |
| 15 Aug 2008filed 18 Aug 2008 | Research Pharmaceutical Servicesoption or derivative | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
News
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Climb 0.9% – Should You Buy?ACXP · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Jack H. Dean; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.